YOLFTbeta
60

Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd

600671 · SHG · Healthcare / Drug Manufacturers - General

16.84CNY-0.31 (-1.81%)

Price History

Full chart

Market Stats

Previous Close17.15
Open17.03
Day Range16.53 – 17.19
52-Week Range15.70 – 24.25
Volume2.16M
Market Cap2.65B
P/E (TTM)198.09
Forward P/E65.79
EPS0.11
Dividend Yield0.00%
Beta0.03
50-Day Avg21.61
200-Day Avg19.83

About

Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, together with its subsidiaries, engages in the pharmaceutical manufacturing and drug distribution businesses in China. The company produces tablets, granules, pills, oral solutions, and other medications; and health food products, including oral liquids, syrups, eye drops, pills, soft capsules, tablets, and granules. It also sells prepared slices of traditional Chinese medicine. In addition, the company operates Chinese medicine clinic; provision of traditional chinese medicine clinic, software development, remote health management, commercial complex management, and internet information services; food business; and sale of health food products. The company was founded in 1958 and is headquartered in Hangzhou, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - General
  • CEOMr. Xuejian Sun
  • Employees392
  • HeadquartersBoya Times Center, Hangzhou, China, 311215, China
  • Websitehttps://www.hztmyy.com

Leadership

  • Mr. Xuejian SunGeneral Manager · b. 1989
  • Mr. Guojun DangCFO, Accounting Suprevisor, Board Secretary & Director · b. 1987
  • Mr. Shengbin JiDeputy General Manager · b. 1974
  • Ms. Yinjun LiDeputy General Manager · b. 1980
  • Mr. Tong Min HanDeputy General Manager · b. 1981

Financials

Income Statement

Currency: CNY1993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue42.96M56.83M65.87M74.12M94.50M129.17M137.76M94.15M144.43M158.24M196.62M209.71M238.71M259.67M265.23M253.98M245.34M234.23M277.27M229.08M281.47M148.73M94.77M123.73M176.38M358.47M297.07M206.63M147.07M108.91M121.78M217.30M211.75M
Growth (%)-+32.27%+15.91%+12.53%+27.49%+36.69%+6.65%-31.66%+53.39%+9.56%+24.26%+6.66%+13.83%+8.78%+2.14%-4.24%-3.40%-4.53%+18.37%-17.38%+22.87%-47.16%-36.28%+30.56%+42.56%+103.23%-17.13%-30.45%-28.82%-25.95%+11.82%+78.44%-2.55%
Cost of Revenue24.89M-50.08M53.22M66.85M87.63M78.80M38.87M75.91M88.01M120.83M128.83M150.85M179.70M184.16M134.75M149.84M129.32M167.41M172.87M197.28M90.37M65.34M78.26M106.99M225.25M154.99M130.29M106.45M93.74M98.37M116.62M110.61M
Gross Profit18.08M56.83M15.79M20.90M27.65M41.55M58.97M55.28M68.52M70.23M75.79M80.88M87.86M79.97M81.07M119.23M95.50M104.91M109.86M56.21M84.19M58.36M29.43M45.46M69.39M133.23M142.08M76.34M40.62M15.16M23.41M100.68M101.14M
Gross Margin42.07%100.00%23.98%28.20%29.26%32.16%42.80%58.71%47.44%44.38%38.55%38.57%36.81%30.80%30.57%46.94%38.93%44.79%39.62%24.54%29.91%39.24%31.05%36.75%39.34%37.16%47.83%36.95%27.62%13.92%19.23%46.33%47.76%
Operating Expense6.37M39.66M-99.33K-3.22M4.24M16.34M43.43M49.33M60.58M64.91M85.48M71.33M80.65M78.92M55.51M120.06M149.84M117.34M79.72M134.30M81.77M54.70M50.69M48.93M81.44M137.14M97.17M133.05M78.62M85.04M60.98M75.56M83.97M
Operating Income11.71M17.17M15.89M24.12M23.41M25.21M15.54M5.95M7.94M5.31M-9.69M9.55M7.20M1.05M25.56M-826.66K-54.34M-12.43M30.14M-78.09M2.42M3.66M-21.27M-3.46M-12.05M-3.92M44.91M-56.71M-38.00M-69.88M-37.57M25.11M17.17M
Operating Margin27.25%30.22%24.13%32.54%24.77%19.52%11.28%6.32%5.50%3.36%-4.93%4.56%3.02%0.40%9.64%-0.33%-22.15%-5.31%10.87%-34.09%0.86%2.46%-22.44%-2.80%-6.83%-1.09%15.12%-27.44%-25.84%-64.17%-30.85%11.56%8.11%
EBITDA7.91M56.83M3.17M3.78M6.32M13.27M17.10M17.98M20.12M20.34M4.36M24.45M23.64M16.23M10.37M18.45M-57.66M5.83M48.45M-69.02M17.97M17.26M-5.76M20.47M28.25M21.61M72.43M-34.83M-16.59M-50.10M-17.90M46.57M42.05M
EBITDA Margin18.41%100.00%4.82%5.10%6.69%10.27%12.41%19.10%13.93%12.86%2.22%11.66%9.90%6.25%3.91%7.26%-23.50%2.49%17.47%-30.13%6.39%11.60%-6.07%16.55%16.02%6.03%24.38%-16.86%-11.28%-46.00%-14.70%21.43%19.86%
Net Income9.96M15.48M13.45M20.84M21.10M22.59M13.86M2.48M3.37M1.96M-11.67M6.90M3.67M386.43K15.12M4.08M-52.24M-8.83M26.44M-88.84M2.11M2.71M-21.54M1.22M8.14M-9.88M50.68M-40.52M-29.80M-67.52M-38.28M15.25M17.62M
Net Income Margin23.18%27.24%20.41%28.11%22.33%17.49%10.06%2.64%2.33%1.24%-5.93%3.29%1.54%0.15%5.70%1.61%-21.29%-3.77%9.54%-38.78%0.75%1.82%-22.73%0.98%4.62%-2.76%17.06%-19.61%-20.26%-62.00%-31.43%7.02%8.32%
R&D-----------------862.77K852.85K759.92K1.69M135.80K190.49K210.15K210.15K7.57M4.78M642.88K1.33M1.58M482.22K1.21M-
R&D as % of Total Revenue-----------------0.37%0.31%0.33%0.60%0.09%0.20%0.17%0.12%2.11%1.61%0.31%0.91%1.45%0.40%0.56%-
Interest Expense--1.25M2.19M---6.69M5.81M5.07M3.02M3.62M4.37M4.21M4.21M7.93M2.91M5.07M8.98M10.12M8.58M7.04M6.92M7.47M7.80M8.97M6.33M7.12M7.51M7.45M7.24M5.65M7.20M
Interest Expense % of Total Revenue--1.90%2.96%---7.11%4.03%3.20%1.54%1.73%1.83%1.62%1.59%3.12%1.18%2.16%3.24%4.42%3.05%4.73%7.30%6.04%4.42%2.50%2.13%3.45%5.10%6.84%5.95%2.60%3.40%

Balance Sheet

Currency: CNY1993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets113.50M192.12M263.02M259.33M295.69M323.01M339.78M405.88M408.75M373.53M346.52M357.85M372.71M352.47M414.09M369.08M328.27M319.79M357.84M295.92M325.27M285.64M280.38M306.19M450.44M480.62M526.93M442.51M402.65M299.84M346.29M441.46M442.03M
Total Liabilities27.02M192.12M89.00M57.82M70.44M87.30M95.68M154.60M157.11M120.32M103.88M105.49M133.32M116.04M131.16M128.78M140.53M165.66M175.00M203.17M230.01M200.40M217.63M240.01M354.18M398.99M393.60M349.18M338.09M295.36M290.34M356.44M348.04M
Total Equity86.48M144.76M172.52M200.91M209.82M220.26M227.65M226.63M224.37M223.55M212.84M221.14M207.49M206.28M228.07M224.84M172.59M140.69M168.01M76.26M78.37M78.74M57.19M58.97M66.15M51.49M101.81M72.84M45.18M-14.63M37.14M52.38M70.01M
Cash7.10M9.31M3.34M43.86M42.07M50.90M67.46M110.74M108.61M108.52M36.25M33.03M37.28M61.51M20.70M29.29M39.23M39.94M35.68M18.19M31.56M29.07M6.84M29.84M40.63M86.81M25.71M7.57M22.29M42.39M97.96M65.72M31.89M
Total Debt19.59M10.29M13.08M31.09M25.45M39.81M47.00M124.51M112.40M75.40M58.51M66.40M89.40M73.90M59.50M60.35M78.00M94.97M103.98M122.00M102.00M94.00M87.00M128.50M132.50M109.40M88.46M113.85M112.76M116.00M109.87M137.22M-
Net Debt12.49M977.00K9.74M-12.77M-16.63M-11.09M-20.46M13.77M3.79M-33.12M22.26M33.37M52.12M12.39M38.80M31.06M38.77M55.03M68.30M103.80M70.44M64.93M80.16M98.66M91.87M22.59M62.75M106.27M90.47M73.61M11.91M71.50M112.41M

Cash Flow

Currency: CNY1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow2.36M49.09M-9.67M10.52M21.80M-41.13M1.35M8.48M55.39M47.53M21.19M7.58M-12.60M-6.49M-19.82M12.37M653.79K-1.47M1.61M24.52M70.71M161.13M-8.40M-26.42M-19.37M-20.43M-36.67M11.79M
Investing Cash Flow7.06M-23.75M-21.34M8.12M20.94M-24.55M-7.41M-11.16M-8.45M-83.74M-8.29M-7.31M-8.45M7.02M1.90M3.32M-25.40M-12.37M-14.35M-22.01M-20.15M-157.62M-11.26M-4.16M-5.80M-8.83M-26.86M-
Financing Cash Flow-587.22K-8.79M74.28M-20.76M-43.05M-21.82M2.83M7.13M-23.42M-5.04M-2.33M9.90M22.26M-4.78M-3.56M1.76M22.26M-8.40M35.74M8.28M-4.63M-70.35M7.51M34.52M56.06M84.83M13.04M-
Capital Expenditure19.10M17.53M14.96M8.97M17.90M10.19M8.42M11.54M13.90M83.83M16.69M28.74M13.53M6.23M583.89K11.61M30.46M12.88M25.21M62.25M37.46M94.66M11.84M4.71M3.52M8.96M20.55M31.18M
Free Cash Flow-16.75M31.56M-24.63M1.55M3.90M-51.32M-7.07M-3.06M41.48M-36.29M4.50M-21.16M-26.13M-12.72M-20.41M760.79K-29.81M-14.35M-23.61M-37.73M33.24M66.47M-20.23M-31.13M-22.89M-29.38M-57.23M-19.39M
Dividends Paid14.96M17.29M9.72M9.29M8.05M4.78M5.06M15.87M6.19M11.53M6.96M4.95M6.12M7.79M10.08M7.99M6.83M6.71M7.02M8.77M9.25M6.08M7.01M6.71M4.78M6.67M8.58M6.50M
FCF to OCF-710.64%64.29%254.72%14.71%17.87%124.77%-522.00%-36.05%74.90%-76.36%21.24%-279.03%207.37%195.97%102.95%6.15%-4558.89%978.79%-1469.12%-153.87%47.02%41.25%240.97%117.83%118.15%143.84%156.04%-164.41%
Dividend Paid to FCF-89.35%54.79%-39.46%600.63%206.63%-9.31%-71.55%-518.82%14.93%-31.76%154.58%-23.37%-23.41%-61.26%-49.39%1049.79%-22.92%-46.78%-29.72%-23.25%27.82%9.15%-34.63%-21.54%-20.88%-22.68%-15.00%-33.52%

Earnings

Report DateSep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Aug 28, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Aug 31, 2020Oct 31, 2020Dec 31, 2020Apr 30, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023
EPS Estimate-----------------------------------
EPS Actual0.020.00-0.03-0.02-0.06-0.07-0.04-0.030.060.01-0.03-0.030.13-0.00-0.020.10-0.02-0.32-0.020.04-0.010.40-0.00-0.02-0.01-0.30-0.03-0.03-0.07-0.12-0.05-0.13-0.07-0.31-0.07
Surprise-----------------------------------
Timing-----------------------------------

Key Statistics & Ratios

Market Cap2.65B
Enterprise Value2.96B
Trailing P/E198.09
Forward P/E65.79
Price / Sales12.79
Price / Book37.18
EPS0.11
Book Value0.627
Revenue (TTM)207.51M
Gross Profit (TTM)106.84M
EBITDA30.69M
Profit Margin6.59%
Operating Margin4.82%
Return on Equity5.98%
Return on Assets2.36%
Shares Outstanding121.78M
Shares Float43.92M
Beta0.03
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20051×
0.16Aug 24, 2005
20021×
0.01Jul 24, 2002
20011×
0.02Jul 6, 2001
19991×
0.09Jun 17, 1999
19981×
0.09Aug 18, 1998